B

Bionovate Technologies Corp
OTC:BIIO

Watchlist Manager
Bionovate Technologies Corp
OTC:BIIO
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 775.4 USD

Profitability Summary

Bionovate Technologies Corp's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Bionovate Technologies Corp

Revenue
0 USD
Operating Expenses
-48k USD
Operating Income
-48k USD
Other Expenses
-57.3k USD
Net Income
-105.3k USD

Margins Comparison
Bionovate Technologies Corp Competitors

Country Company Market Cap Operating
Margin
Net
Margin
CH
Bionovate Technologies Corp
OTC:BIIO
775.4 USD N/A N/A
US
Abbott Laboratories
NYSE:ABT
213.3B USD
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
192.1B USD
29%
29%
US
Stryker Corp
NYSE:SYK
139.2B USD
22%
12%
US
Boston Scientific Corp
NYSE:BSX
132B USD
19%
14%
IE
Medtronic PLC
NYSE:MDT
125.4B USD
19%
14%
DE
Siemens Healthineers AG
XETRA:SHL
52.1B EUR
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
59.6B USD
16%
8%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57B USD
31%
25%
US
Edwards Lifesciences Corp
NYSE:EW
48.9B USD
28%
23%
US
Resmed Inc
NYSE:RMD
37.7B USD
33%
27%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Bionovate Technologies Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CH
Bionovate Technologies Corp
OTC:BIIO
775.4 USD
22%
N/A
10%
126%
US
Abbott Laboratories
NYSE:ABT
213.3B USD
31%
18%
12%
20%
US
Intuitive Surgical Inc
NASDAQ:ISRG
192.1B USD
17%
15%
17%
22%
US
Stryker Corp
NYSE:SYK
139.2B USD
14%
6%
14%
12%
US
Boston Scientific Corp
NYSE:BSX
132B USD
13%
7%
11%
9%
IE
Medtronic PLC
NYSE:MDT
125.4B USD
10%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
52.1B EUR
12%
5%
10%
6%
US
Becton Dickinson and Co
NYSE:BDX
59.6B USD
7%
3%
7%
6%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57B USD
65%
31%
58%
35%
US
Edwards Lifesciences Corp
NYSE:EW
48.9B USD
14%
10%
14%
16%
US
Resmed Inc
NYSE:RMD
37.7B USD
25%
19%
26%
22%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less